Ambalal Sarabhai Enterprises touches roof on getting nod to enter into SPA with Asence Pharma

27 Nov 2020 Evaluate

Ambalal Sarabhai Enterprises is currently trading at its upper circuit limit of Rs. 21.15, up by 1.00 points or 4.96% from its previous closing of Rs. 20.15 on the BSE.

The scrip opened at Rs. 21.15 and has touched a high and low of Rs. 21.15 and Rs. 20.65 respectively. So far 84582 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.95 on 20-Aug-2020 and a 52 week low of Rs. 10.01 on 02-Dec-2019.

Last one week high and low of the scrip stood at Rs. 21.15 and Rs. 18.85 respectively. The current market cap of the company is Rs. 162.08 crore.

The promoters holding in the company stood at 30.76%, while Institutions and Non-Institutions held 0.01% and 69.24% respectively.

Ambalal Sarabhai Enterprises has received approval to enter into Share Purchase Agreement (SPA) with Asence Pharma for sale of 120446 (35,000 equity shares of face value of Rs 1000 each Rs 100 paid up, and 85,446 equity shares of face value of Rs 1000 each Rs 1000 paid up aggregating 120,446 equity shares) equity shares of Synbiotics, a wholly owned subsidiary to Asence Pharma, another subsidiary of the Company on consideration of Rs 11,91,87,640.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

48.03 0.23 (0.48%)
01-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1517.90
Dr. Reddys Lab 6362.00
Cipla 1478.90
Zydus Lifesciences 1066.95
Lupin 1614.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.